SCHEMBL3983968

SCHEMBL3983968

CN1CCn2c(c(O)c3c(=O)n(Cc4ccc(F)c(Cl)c4)nc(C(=O)N4CCOCC4)c32)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 9/20 0.39
PIK3CA P42336 9/20 0.39
PIK3CB P42338 9/20 0.39
PIK3R2 O00459 8/20 0.39
PIK3CG P48736 8/20 0.39
PIK3R5 Q8WYR1 8/20 0.39
PIK3R3 Q92569 8/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
AVPR1B P47901 2/20 0.36
GAA P10253 1/20 0.35
PARP1 P09874 1/20 0.35
CNR2 P34972 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3982265 0.93 PARP1 (0.36) PIK3CDPIK3CAPIK3CBPIK3R2PIK3CG
SCHEMBL3985369 0.93 LMNA (0.36) AVPR1BPARP1MAPTTSHRALDH1A1
SCHEMBL3985842 0.91 PIK3CD (0.39) PIK3CDPIK3CAPIK3CBPIK3R2PIK3CG
SCHEMBL3981550 0.91 PIK3CD (0.33) PIK3CDPIK3CAPIK3CBPIK3R2PIK3CG
SCHEMBL3985220 0.90 PARP1 (0.41) PARP1MAPTTSHRALDH1A1
SCHEMBL3987232 0.89 PTGER4 (0.35) PIK3CAAVPR1BCNR2
SCHEMBL1387060 0.88 ALDH1A1 (0.36) CYP3A4CYP2C19GAAPARP1MAPT
SCHEMBL3988126 0.88 PTGER4 (0.34) PIK3CDPIK3CAPIK3CBAVPR1BCNR2
SCHEMBL3982488 0.86 PTGER4 (0.33) PIK3CDPIK3CAPIK3CBPIK3CGAVPR1B
SCHEMBL3984446 0.86 PTGER4 (0.37) PIK3CAAVPR1BCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US claimed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US claimed
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP PIK3CD 252/4885PIK3CA 98/4885PIK3CB 300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.